aTyr Pharma, Inc. (ATYR)

aTyr Pharma Stock Forecast

Stock Price Forecast

The 5 analysts that cover aTyr Pharma stock have a consensus rating of "Hold" and an average price target of $4.20, which forecasts a 367.19% increase in the stock price over the next year. The lowest target is $1.00 and the highest is $17.

Price Target: $4.20 (+367.19%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$1.00	$4.20	$1.00	$17
Change	+11.23%	+367.19%	+11.23%	+1791.0%

* Price targets were last updated on Nov 7, 2025.

Analyst Ratings

The average analyst rating for aTyr Pharma stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	7	7	7	7	7	7
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Brian Abrahams RBC Capital	RBC Capital	Hold Maintains $1.5 → $1	Hold	Maintains	$1.5 → $1	+11.23%	Nov 7, 2025
Derek Archila Wells Fargo	Wells Fargo	Buy → Hold Downgrades $25 → $1	Buy → Hold	Downgrades	$25 → $1	+11.23%	Sep 16, 2025
Brian Abrahams RBC Capital	RBC Capital	Buy → Hold Downgrades $16 → $1.5	Buy → Hold	Downgrades	$16 → $1.5	+66.85%	Sep 16, 2025
Faisal Khurshid Leerink Partners	Leerink Partners	Buy → Hold Downgrades $1	Buy → Hold	Downgrades	$1	+11.23%	Sep 15, 2025
Soumit Roy Jones Trading	Jones Trading	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Sep 15, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

112.20K

Decreased by -52.26%

from 235.00K

Revenue Next Year

21.13M

Increased by 18,728.88%

from 112.20K

EPS This Year

-0.86

from -0.86

EPS Next Year

-0.64

from -0.86

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	10.46M	-	10.39M	353.00K	235.00K	112.20K	21.13M
Revenue Growth	2,377.49%	-	-	-96.60%	-33.43%	-52.26%	18,728.88%
EPS	-1.77	-1.77	-1.60	-0.94	-0.86	-0.86	-0.64
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	12	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	409,500	123.9M
Avg	112,200	21.1M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	74.3%	110,327.8%
Avg	-52.3%	18,728.9%
Low	-	-

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-0.81	-0.37
Avg	-0.86	-0.64
Low	-0.92	-0.80

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.